For some American voters, the news of Mr. Trump's victory in the 2016 presidential election caused recurrent emotions that were negative, persistent, and intense enough to elicit repeated attempts at emotion regulation. This afforded a rare opportunity to analyse the regulation of recurrent emotions in a natural, non-laboratory context. The regulation of recurrent emotion involves additional considerations relative to single-instance emotion, such as representations of past and future encounters with the emotion-eliciting variables, ongoing consequences of each regulatory episode, and a tendency to repeatedly deploy emotion regulation strategies that one is most familiar with in the context of the particular recurrent emotion. Despite the ubiquitous nature of recurrent emotions, its associated regulatory processes have been infrequently examined and are not well-understood. Over eight days (11/10/16-11/18/16), we administered four surveys to 202 participants who voted against Mr. Trump. We examined the determinants and outcomes of regulatory strategies in the context of recurrent emotion. We found that (1) reappraisal (compared to distraction and acceptance) was associated with greater decline in emotion intensity, (2) high-intensity emotions were more likely to be distracted, whereas low-intensity emotions were more likely to be reappraised, and (3) strategy variability was associated with greater affective adaptation.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02699931.2019.1682970DOI Listing

Publication Analysis

Top Keywords

regulation recurrent
12
recurrent emotions
12
recurrent emotion
12
emotion
8
emotion regulation
8
context recurrent
8
associated greater
8
recurrent
6
regulation
5
emotions
5

Similar Publications

Tongue squamous cell carcinoma (TSCC) is a common malignant oral cancer characterized by substantial invasion, a high rate of lymph node and distant metastasis, and a high recurrence rate. This study aims to provide new ideas for the diagnosis and treatment of TSCC patients by exploring the related mechanisms that affect the migration and invasion of TSCC and inhibit the migration and spread of cancer cells. The results indicated the rate of high expression of IL-17 in cancer tissues was greater than that in tongue tissues, and the expression of IL-17 was related to the TNM stage.

View Article and Find Full Text PDF

A safe haven for cancer cells: tumor plus stroma control by DYRK1B.

Oncogene

January 2025

Department of Gastroenterology, Endocrinology and Metabolism, Center for Tumor and Immune Biology, Philipps University Marburg, Marburg, Germany.

The development of resistance remains one of the biggest challenges in clinical cancer patient care and it comprises all treatment modalities from chemotherapy to targeted or immune therapy. In solid malignancies, drug resistance is the result of adaptive processes occurring in cancer cells or the surrounding tumor microenvironment (TME). Future therapy attempts will therefore benefit from targeting both, tumor and stroma compartments and drug targets which affect both sides will be highly appreciated.

View Article and Find Full Text PDF

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment.

Cell Death Dis

January 2025

Department of Organ Transplantation and Hepatobiliary Surgery, Key Laboratory of Organ Transplantation of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.

TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy. Being the first targeted regimen for advanced liver cancer, sorafenib has limited efficacy in HBV-positive patients.

View Article and Find Full Text PDF

Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies.

Biochim Biophys Acta Rev Cancer

January 2025

Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau, China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau, China. Electronic address:

Chemoresistance is a multifactorial phenomenon and the primary cause to the ineffectiveness of oncotherapy and cancer recurrence. Membrane drug transporters are crucial for drug delivery and disposition in cancer cells. Changes in the expression and functionality of these transporters lead to decreased intracellular accumulation and reduced toxicity of antineoplastic drugs.

View Article and Find Full Text PDF

Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation.

Int J Pharm

January 2025

CIDETEC, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Gipuzkoa, Donostia-San Sebastián, Spain; Kusudama Therapeutics SA, Parque Científico y Tecnológico de Gipuzkoa, Donostia-San Sebastián, Spain; Biogipuzkoa Health Research Institute, Group of Innovation, 20014 San Sebastian, Spain.

Cystic fibrosis (CF) is characterized by abnormal mucus hydration due to a defective CF Transmembrane Regulator (CFTR) protein, leading to the production of difficult-to-clear mucus. This causes airflow obstruction, recurrent infections, and respiratory complications. Chronic lung infections are the leading cause of death for CF patients and inhaled tobramycin is the first-in-line antibiotic treatment against these infections, mainly caused by Pseudomonas aeruginosa in adult patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!